QY Research > レポート一覧 > 医療機器と消耗材 > 分子細胞遺伝学世界市場の発展状況と動向 2024-2030

分子細胞遺伝学世界市場の発展状況と動向 2024-2030

英文タイトル: Global Molecular Cytogenetics Market Insights, Forecast to 2030

分子細胞遺伝学世界市場の発展状況と動向 2024-2030
  • レポートID:272845
  • 発表時期:2024-04-25
  • 訪問回数:972
  • ページ数:108
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:136
  • レポートカテゴリ: 医療機器と消耗材

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は分子細胞遺伝学市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは分子細胞遺伝学の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の分子細胞遺伝学市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは分子細胞遺伝学のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に分子細胞遺伝学市場を分類しています。本研究に含まれる主な企業は:Abbott Laboratories、Agilent Technologies、Applied Spectral Imaging、Bio-Rad Laboratories、Danaher、Illumina、Oxford Gene Technology、Perkinelmer、F. Hoffmann-La Roche、Thermo Fisher Scientific

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Non-Radioactive In Situ Hybridization
Comparative Genomic Hybridization
In Situ Hybridization

用途別の市場セグメント:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Diagnostic Centers
Other

レポートの詳細内容
世界の分子細胞遺伝学市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、分子細胞遺伝学タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の分子細胞遺伝学収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の分子細胞遺伝学市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、分子細胞遺伝学市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

分子細胞遺伝学のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:分子細胞遺伝学のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:分子細胞遺伝学の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3分子細胞遺伝学企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:分子細胞遺伝学の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:分子細胞遺伝学の主要企業の概要を提供し、製品の説明と仕様、分子細胞遺伝学の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region.

Market Analysis and Insights: Global Molecular Cytogenetics Market
The global Molecular Cytogenetics market is projected to grow from US$ 1764.7 million in 2024 to US$ 2816 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period.
Geographically, North America dominates the global molecular cytogenetics market.

Report Covers:
This report presents an overview of global market for Molecular Cytogenetics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Molecular Cytogenetics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Cytogenetics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Molecular Cytogenetics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Molecular Cytogenetics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Molecular Cytogenetics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Agilent Technologies, Applied Spectral Imaging, Bio-Rad Laboratories, Danaher, Illumina, Oxford Gene Technology, Perkinelmer and F. Hoffmann-La Roche, etc.
Market Segmentation
By Company
    Abbott Laboratories
    Agilent Technologies
    Applied Spectral Imaging
    Bio-Rad Laboratories
    Danaher
    Illumina
    Oxford Gene Technology
    Perkinelmer
    F. Hoffmann-La Roche
    Thermo Fisher Scientific

Segment by Type
    Non-Radioactive In Situ Hybridization
    Comparative Genomic Hybridization
    In Situ Hybridization

Segment by Application
    Pharmaceutical and Biotechnology Companies
    Academic and Research Institutes
    Hospitals and Diagnostic Centers
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Molecular Cytogenetics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Cytogenetics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Cytogenetics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Cytogenetics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Non-Radioactive In Situ Hybridization
1.2.3 Comparative Genomic Hybridization
1.2.4 In Situ Hybridization
1.3 Market by Application
1.3.1 Global Molecular Cytogenetics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutes
1.3.4 Hospitals and Diagnostic Centers
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Molecular Cytogenetics Market Perspective (2019-2030)
2.2 Global Molecular Cytogenetics Growth Trends by Region
2.2.1 Molecular Cytogenetics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Cytogenetics Historic Market Size by Region (2019-2024)
2.2.3 Molecular Cytogenetics Forecasted Market Size by Region (2025-2030)
2.3 Molecular Cytogenetics Market Dynamics
2.3.1 Molecular Cytogenetics Industry Trends
2.3.2 Molecular Cytogenetics Market Drivers
2.3.3 Molecular Cytogenetics Market Challenges
2.3.4 Molecular Cytogenetics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Molecular Cytogenetics by Players
3.1.1 Global Molecular Cytogenetics Revenue by Players (2019-2024)
3.1.2 Global Molecular Cytogenetics Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Cytogenetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Molecular Cytogenetics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Molecular Cytogenetics Market Concentration Ratio
3.4.1 Global Molecular Cytogenetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Cytogenetics Revenue in 2023
3.5 Global Key Players of Molecular Cytogenetics Head office and Area Served
3.6 Global Key Players of Molecular Cytogenetics, Product and Application
3.7 Global Key Players of Molecular Cytogenetics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Cytogenetics Breakdown Data by Type
4.1 Global Molecular Cytogenetics Historic Market Size by Type (2019-2024)
4.2 Global Molecular Cytogenetics Forecasted Market Size by Type (2025-2030)

5 Molecular Cytogenetics Breakdown Data by Application
5.1 Global Molecular Cytogenetics Historic Market Size by Application (2019-2024)
5.2 Global Molecular Cytogenetics Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Molecular Cytogenetics Market Size (2019-2030)
6.2 North America Molecular Cytogenetics Market Size by Type
6.2.1 North America Molecular Cytogenetics Market Size by Type (2019-2024)
6.2.2 North America Molecular Cytogenetics Market Size by Type (2025-2030)
6.2.3 North America Molecular Cytogenetics Market Share by Type (2019-2030)
6.3 North America Molecular Cytogenetics Market Size by Application
6.3.1 North America Molecular Cytogenetics Market Size by Application (2019-2024)
6.3.2 North America Molecular Cytogenetics Market Size by Application (2025-2030)
6.3.3 North America Molecular Cytogenetics Market Share by Application (2019-2030)
6.4 North America Molecular Cytogenetics Market Size by Country
6.4.1 North America Molecular Cytogenetics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Molecular Cytogenetics Market Size by Country (2019-2024)
6.4.3 North America Molecular Cytogenetics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Molecular Cytogenetics Market Size (2019-2030)
7.2 Europe Molecular Cytogenetics Market Size by Type
7.2.1 Europe Molecular Cytogenetics Market Size by Type (2019-2024)
7.2.2 Europe Molecular Cytogenetics Market Size by Type (2025-2030)
7.2.3 Europe Molecular Cytogenetics Market Share by Type (2019-2030)
7.3 Europe Molecular Cytogenetics Market Size by Application
7.3.1 Europe Molecular Cytogenetics Market Size by Application (2019-2024)
7.3.2 Europe Molecular Cytogenetics Market Size by Application (2025-2030)
7.3.3 Europe Molecular Cytogenetics Market Share by Application (2019-2030)
7.4 Europe Molecular Cytogenetics Market Size by Country
7.4.1 Europe Molecular Cytogenetics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Molecular Cytogenetics Market Size by Country (2019-2024)
7.4.3 Europe Molecular Cytogenetics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Molecular Cytogenetics Market Size (2019-2030)
8.2 China Molecular Cytogenetics Market Size by Type
8.2.1 China Molecular Cytogenetics Market Size by Type (2019-2024)
8.2.2 China Molecular Cytogenetics Market Size by Type (2025-2030)
8.2.3 China Molecular Cytogenetics Market Share by Type (2019-2030)
8.3 China Molecular Cytogenetics Market Size by Application
8.3.1 China Molecular Cytogenetics Market Size by Application (2019-2024)
8.3.2 China Molecular Cytogenetics Market Size by Application (2025-2030)
8.3.3 China Molecular Cytogenetics Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Molecular Cytogenetics Market Size (2019-2030)
9.2 Asia Molecular Cytogenetics Market Size by Type
9.2.1 Asia Molecular Cytogenetics Market Size by Type (2019-2024)
9.2.2 Asia Molecular Cytogenetics Market Size by Type (2025-2030)
9.2.3 Asia Molecular Cytogenetics Market Share by Type (2019-2030)
9.3 Asia Molecular Cytogenetics Market Size by Application
9.3.1 Asia Molecular Cytogenetics Market Size by Application (2019-2024)
9.3.2 Asia Molecular Cytogenetics Market Size by Application (2025-2030)
9.3.3 Asia Molecular Cytogenetics Market Share by Application (2019-2030)
9.4 Asia Molecular Cytogenetics Market Size by Region
9.4.1 Asia Molecular Cytogenetics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Molecular Cytogenetics Market Size by Region (2019-2024)
9.4.3 Asia Molecular Cytogenetics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Molecular Cytogenetics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Molecular Cytogenetics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Cytogenetics Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Cytogenetics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Molecular Cytogenetics Introduction
11.2.4 Agilent Technologies Revenue in Molecular Cytogenetics Business (2019-2024)
11.2.5 Agilent Technologies Recent Developments
11.3 Applied Spectral Imaging
11.3.1 Applied Spectral Imaging Company Details
11.3.2 Applied Spectral Imaging Business Overview
11.3.3 Applied Spectral Imaging Molecular Cytogenetics Introduction
11.3.4 Applied Spectral Imaging Revenue in Molecular Cytogenetics Business (2019-2024)
11.3.5 Applied Spectral Imaging Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Molecular Cytogenetics Introduction
11.4.4 Bio-Rad Laboratories Revenue in Molecular Cytogenetics Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Developments
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Molecular Cytogenetics Introduction
11.5.4 Danaher Revenue in Molecular Cytogenetics Business (2019-2024)
11.5.5 Danaher Recent Developments
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Molecular Cytogenetics Introduction
11.6.4 Illumina Revenue in Molecular Cytogenetics Business (2019-2024)
11.6.5 Illumina Recent Developments
11.7 Oxford Gene Technology
11.7.1 Oxford Gene Technology Company Details
11.7.2 Oxford Gene Technology Business Overview
11.7.3 Oxford Gene Technology Molecular Cytogenetics Introduction
11.7.4 Oxford Gene Technology Revenue in Molecular Cytogenetics Business (2019-2024)
11.7.5 Oxford Gene Technology Recent Developments
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Molecular Cytogenetics Introduction
11.8.4 Perkinelmer Revenue in Molecular Cytogenetics Business (2019-2024)
11.8.5 Perkinelmer Recent Developments
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Company Details
11.9.2 F. Hoffmann-La Roche Business Overview
11.9.3 F. Hoffmann-La Roche Molecular Cytogenetics Introduction
11.9.4 F. Hoffmann-La Roche Revenue in Molecular Cytogenetics Business (2019-2024)
11.9.5 F. Hoffmann-La Roche Recent Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Molecular Cytogenetics Introduction
11.10.4 Thermo Fisher Scientific Revenue in Molecular Cytogenetics Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Molecular Cytogenetics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Non-Radioactive In Situ Hybridization
    Table 3. Key Players of Comparative Genomic Hybridization
    Table 4. Key Players of In Situ Hybridization
    Table 5. Global Molecular Cytogenetics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Molecular Cytogenetics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Molecular Cytogenetics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Molecular Cytogenetics Market Share by Region (2019-2024)
    Table 9. Global Molecular Cytogenetics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Molecular Cytogenetics Market Share by Region (2025-2030)
    Table 11. Molecular Cytogenetics Market Trends
    Table 12. Molecular Cytogenetics Market Drivers
    Table 13. Molecular Cytogenetics Market Challenges
    Table 14. Molecular Cytogenetics Market Restraints
    Table 15. Global Molecular Cytogenetics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Molecular Cytogenetics Revenue Share by Players (2019-2024)
    Table 17. Global Top Molecular Cytogenetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cytogenetics as of 2023)
    Table 18. Global Molecular Cytogenetics Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Molecular Cytogenetics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Molecular Cytogenetics, Headquarters and Area Served
    Table 21. Global Key Players of Molecular Cytogenetics, Product and Application
    Table 22. Global Key Players of Molecular Cytogenetics, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Molecular Cytogenetics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Molecular Cytogenetics Revenue Market Share by Type (2019-2024)
    Table 26. Global Molecular Cytogenetics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Molecular Cytogenetics Revenue Market Share by Type (2025-2030)
    Table 28. Global Molecular Cytogenetics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Molecular Cytogenetics Revenue Share by Application (2019-2024)
    Table 30. Global Molecular Cytogenetics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Molecular Cytogenetics Revenue Share by Application (2025-2030)
    Table 32. North America Molecular Cytogenetics Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Molecular Cytogenetics Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Molecular Cytogenetics Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Molecular Cytogenetics Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Molecular Cytogenetics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Molecular Cytogenetics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Molecular Cytogenetics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Molecular Cytogenetics Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Molecular Cytogenetics Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Molecular Cytogenetics Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Molecular Cytogenetics Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Molecular Cytogenetics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Molecular Cytogenetics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Molecular Cytogenetics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Molecular Cytogenetics Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Molecular Cytogenetics Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Molecular Cytogenetics Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Molecular Cytogenetics Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Molecular Cytogenetics Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Molecular Cytogenetics Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Molecular Cytogenetics Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Molecular Cytogenetics Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Molecular Cytogenetics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Molecular Cytogenetics Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Molecular Cytogenetics Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Molecular Cytogenetics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Abbott Laboratories Company Details
    Table 65. Abbott Laboratories Business Overview
    Table 66. Abbott Laboratories Molecular Cytogenetics Product
    Table 67. Abbott Laboratories Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 68. Abbott Laboratories Recent Developments
    Table 69. Agilent Technologies Company Details
    Table 70. Agilent Technologies Business Overview
    Table 71. Agilent Technologies Molecular Cytogenetics Product
    Table 72. Agilent Technologies Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 73. Agilent Technologies Recent Developments
    Table 74. Applied Spectral Imaging Company Details
    Table 75. Applied Spectral Imaging Business Overview
    Table 76. Applied Spectral Imaging Molecular Cytogenetics Product
    Table 77. Applied Spectral Imaging Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 78. Applied Spectral Imaging Recent Developments
    Table 79. Bio-Rad Laboratories Company Details
    Table 80. Bio-Rad Laboratories Business Overview
    Table 81. Bio-Rad Laboratories Molecular Cytogenetics Product
    Table 82. Bio-Rad Laboratories Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 83. Bio-Rad Laboratories Recent Developments
    Table 84. Danaher Company Details
    Table 85. Danaher Business Overview
    Table 86. Danaher Molecular Cytogenetics Product
    Table 87. Danaher Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 88. Danaher Recent Developments
    Table 89. Illumina Company Details
    Table 90. Illumina Business Overview
    Table 91. Illumina Molecular Cytogenetics Product
    Table 92. Illumina Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 93. Illumina Recent Developments
    Table 94. Oxford Gene Technology Company Details
    Table 95. Oxford Gene Technology Business Overview
    Table 96. Oxford Gene Technology Molecular Cytogenetics Product
    Table 97. Oxford Gene Technology Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 98. Oxford Gene Technology Recent Developments
    Table 99. Perkinelmer Company Details
    Table 100. Perkinelmer Business Overview
    Table 101. Perkinelmer Molecular Cytogenetics Product
    Table 102. Perkinelmer Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 103. Perkinelmer Recent Developments
    Table 104. F. Hoffmann-La Roche Company Details
    Table 105. F. Hoffmann-La Roche Business Overview
    Table 106. F. Hoffmann-La Roche Molecular Cytogenetics Product
    Table 107. F. Hoffmann-La Roche Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 108. F. Hoffmann-La Roche Recent Developments
    Table 109. Thermo Fisher Scientific Company Details
    Table 110. Thermo Fisher Scientific Business Overview
    Table 111. Thermo Fisher Scientific Molecular Cytogenetics Product
    Table 112. Thermo Fisher Scientific Revenue in Molecular Cytogenetics Business (2019-2024) & (US$ Million)
    Table 113. Thermo Fisher Scientific Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Molecular Cytogenetics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Molecular Cytogenetics Market Share by Type: 2023 VS 2030
    Figure 3. Non-Radioactive In Situ Hybridization Features
    Figure 4. Comparative Genomic Hybridization Features
    Figure 5. In Situ Hybridization Features
    Figure 6. Global Molecular Cytogenetics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Molecular Cytogenetics Market Share by Application: 2023 VS 2030
    Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 9. Academic and Research Institutes Case Studies
    Figure 10. Hospitals and Diagnostic Centers Case Studies
    Figure 11. Other Case Studies
    Figure 12. Molecular Cytogenetics Report Years Considered
    Figure 13. Global Molecular Cytogenetics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Molecular Cytogenetics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Molecular Cytogenetics Market Share by Region: 2023 VS 2030
    Figure 16. Global Molecular Cytogenetics Market Share by Players in 2023
    Figure 17. Global Top Molecular Cytogenetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cytogenetics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Molecular Cytogenetics Revenue in 2023
    Figure 19. North America Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Molecular Cytogenetics Market Share by Type (2019-2030)
    Figure 21. North America Molecular Cytogenetics Market Share by Application (2019-2030)
    Figure 22. North America Molecular Cytogenetics Market Share by Country (2019-2030)
    Figure 23. United States Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Molecular Cytogenetics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Molecular Cytogenetics Market Share by Type (2019-2030)
    Figure 27. Europe Molecular Cytogenetics Market Share by Application (2019-2030)
    Figure 28. Europe Molecular Cytogenetics Market Share by Country (2019-2030)
    Figure 29. Germany Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Molecular Cytogenetics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Molecular Cytogenetics Market Share by Type (2019-2030)
    Figure 37. China Molecular Cytogenetics Market Share by Application (2019-2030)
    Figure 38. Asia Molecular Cytogenetics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Molecular Cytogenetics Market Share by Type (2019-2030)
    Figure 40. Asia Molecular Cytogenetics Market Share by Application (2019-2030)
    Figure 41. Asia Molecular Cytogenetics Market Share by Region (2019-2030)
    Figure 42. Japan Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Molecular Cytogenetics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Molecular Cytogenetics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Molecular Cytogenetics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Molecular Cytogenetics Market Share by Country (2019-2030)
    Figure 52. Brazil Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Molecular Cytogenetics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Abbott Laboratories Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 59. Agilent Technologies Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 60. Applied Spectral Imaging Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 62. Danaher Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 63. Illumina Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 64. Oxford Gene Technology Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 65. Perkinelmer Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Molecular Cytogenetics Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)